Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Atorvastatin and Fenofibric Acid in Healthy Males
NCT02422030Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Mar 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin and fenofibric acid in dyslipidemia (6 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Curve over the dosing interval and Maximum Steady State Concentration. Started Mar 2015; status: completed.
02
Drugs
atorvastatinfenofibric acid
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02422030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422030.